Zobrazeno 1 - 10
of 83
pro vyhledávání: '"N D, Selezneva"'
Autor:
I. K. Malashenkova, D. P. Ogurtsov, S. A. Krynskiy, N. A. Khailov, N. D. Selezneva, Ya. B. Fedorova, E. V. Ponomareva, I. V. Kolykhalov, S. I. Gavrilova, N. A. Didkovsky
Publikováno v:
Медицинская иммунология, Vol 23, Iss 4, Pp 805-812 (2021)
Alzheimer’s disease (AD) is currently the most common cause of dementia. A significant role in the pathogenesis of AD belongs to the activation of the mechanisms of neuroinflammation. There is a hypothesis that chronic infections may play a role in
Externí odkaz:
https://doaj.org/article/2506c94e7ca240439731c6d73451d236
Publikováno v:
Psikhiatriya. 21:52-61
The aim of the study: evaluation of the impact of long-term effects of repeated courses of Actovegin therapy on indicators of minimal cognitive dysfunction (MCD) in relatives of patients with Alzheimer’s disease (AD).Study participant: 76 people wi
Autor:
B. B. Velichkovsky, D. V. Tatarinov, A. A. Khlebnikova, I. F. Roshchina, N. D. Selezneva, S. I. Gavrilova
Publikováno v:
Neuroscience and Behavioral Physiology. 51:1216-1221
Autor:
L. O. Minushkina, O. S. Chumakova, N. D. Selezneva, V. A. Evdokimova, V. S. Osmolovskata, K. A. Blagodatskikh, V. V. Nosikov, D. A. Zateyshchikov
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 10, Pp 23-28 (2014)
Aim. To study the association of polymorphic markers of C-reactive protein genes (CRP), interleukine-6 (IL6), interleukine-10 (IL10), lymphotoxine alpha (LTA) and tumornecrosis factor alpha (TNFA) with LVH in patients with hypertensive disease (AH).M
Externí odkaz:
https://doaj.org/article/a316c88999a44053ae3d99f84da76c47
Autor:
B B, Velichkovsky, D V, Tatarinov, A A, Khlebnikova, A V, Ziberova, I F, Roshchina, N D, Selezneva, S I, Gavrilova
Publikováno v:
Advances in gerontology = Uspekhi gerontologii. 33(5)
Conflict adaptation effect in interference control tasks (like Stroop task or flanker task) consists in better interference suppression in incongruent trials following an incongruent trial. In a flanker task is shown that in normal cognitive aging th
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 121:30
To study the effects of a three-month course of therapy with citicoline, aimed at preventing the progression of cognitive deficit in 1st-degree relatives of patients with Alzheimer's disease (AD), depending on the carriage of theStudy participants: 8
Autor:
N A Didkovsky, S A Krynskiy, Ya. B. Fedorova, I A Kompaneetz, I K Malashenkova, I. V. Kolyhalov, G. V. Kazanova, N A Hailov, S I Gavrilova, E. V. Ponomareva, N D Selezneva, D P Ogurtsov, M A Zharova
Publikováno v:
Russian Journal of Allergy. 13:90-91
Autor:
N. D. Selezneva, T. P. Serkova, T. V. Abramenko, I. V. Kolykhalov, N. N. Lermontova, Sergey O. Bachurin, G.A. Zharikov, Ya. B. Kalyn, S. I. Gavrilova, M. A. Myagkova
Publikováno v:
Bulletin of Experimental Biology and Medicine. 136:49-52
We measured serum content of autoantibodies to β-amyloid protein Aβ1-42, its neurotoxic fragment Aβ25-35, vasopressin, bradykinin, thrombin, antithrombin III, α2-macroglobulin, and angiotensin II in patients with various forms of Alzheimer's deme
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 114(9)
Objective. To determine the therapeutic efficacy and safety of agomelatine (valdoxan) in elderly patients with mild and moderate depression during outpatient treatment. Material and methods. The 60-79-year-old age group consisted of 20 patients with